{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:38:02Z","timestamp":1791023882454,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2004,3,16]],"date-time":"2004-03-16T00:00:00Z","timestamp":1079395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,3,16]],"date-time":"2004-03-16T00:00:00Z","timestamp":1079395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2004,9,1]]},"DOI":"10.1038\/sj.mp.4001490","type":"journal-article","created":{"date-parts":[[2004,3,16]],"date-time":"2004-03-16T10:22:20Z","timestamp":1079432540000},"page":"846-858","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner"],"prefix":"10.1038","volume":"9","author":[{"given":"G","family":"Rammes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Eisensamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Shapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gimpl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Gilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Riering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Hapfelmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Bondy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Zieglg\u00e4nsberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Holsboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,3,16]]},"reference":[{"key":"BF4001490_CR1","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","volume":"38","author":"NM Barnes","year":"1999","unstructured":"Barnes NM, Sharp T . A review of central 5-HT receptors and their function. Neuropharmacology 1999; 38: 1083\u20131152.","journal-title":"Neuropharmacology"},{"key":"BF4001490_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0166-2236(00)01662-3","volume":"23","author":"JA van Hooft","year":"2000","unstructured":"van Hooft JA, Vijverberg HP . 5-HT3 receptors and neurotransmitter release in the CNS: a nerve ending story? Trends Neurosci 2000; 23: 605\u2013610.","journal-title":"Trends Neurosci"},{"key":"BF4001490_CR3","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1046\/j.1471-4159.1998.70031094.x","volume":"70","author":"P Ronde","year":"1998","unstructured":"Ronde P, Nichols RA . High calcium permeability of serotonin 5-HT3 receptors on presynaptic nerve terminals from rat striatum. J Neurochem 1998; 70: 1094\u20131103.","journal-title":"J Neurochem"},{"key":"BF4001490_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0896-6273(92)90121-S","volume":"8","author":"S Sugita","year":"1992","unstructured":"Sugita S, Shen KZ, North RA . 5-hydroxytryptamine is a fast excitatory transmitter at 5-HT3 receptors in rat amygdala. Neuron 1992; 8: 199\u2013203.","journal-title":"Neuron"},{"key":"BF4001490_CR5","doi-asserted-by":"publisher","first-page":"8353","DOI":"10.1523\/JNEUROSCI.17-21-08353.1997","volume":"17","author":"B Roerig","year":"1997","unstructured":"Roerig B, Nelson DA, Katz LC . Fast synaptic signaling by nicotinic acetylcholine and serotonin 5-HT3 receptors in developing visual cortex. J Neurosci 1997; 17: 8353\u20138362.","journal-title":"J Neurosci"},{"key":"BF4001490_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0304-3940(95)12063-A","volume":"199","author":"RJ Siarey","year":"1995","unstructured":"Siarey RJ, Andreasen M, Lambert JD . Serotoninergic modulation of excitability in area CA1 of the in vitro rat hippocampus. Neurosci Lett 1995; 199: 211\u2013214.","journal-title":"Neurosci Lett"},{"key":"BF4001490_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/978-3-642-60921-3_16","volume-title":"Serotoninergic Neurons and 5-HT Receptors in the CNS","author":"B Costall","year":"2000","unstructured":"Costall B, Naylor RJ . Neuropharmacology of 5-HT3 receptor ligands. In: Baumgarten HG, Gothert M (eds). Serotoninergic Neurons and 5-HT Receptors in the CNS. Springer: Berlin, Heidelberg, 2000 pp 409\u2013438."},{"key":"BF4001490_CR8","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1152\/jn.1999.82.6.2989","volume":"82","author":"FM Zhou","year":"1999","unstructured":"Zhou FM, Hablitz JJ . Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J Neurophysiol 1999; 82: 2989\u20132999.","journal-title":"J Neurophysiol"},{"key":"BF4001490_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev.neuro.22.1.443","volume":"22","author":"AB MacDermott","year":"1999","unstructured":"MacDermott AB, Role LW, Siegelbaum SA . Presynaptic ionotropic receptors and the control of transmitter release. Ann Rev Neurosci 1999; 22: 443\u2013485.","journal-title":"Ann Rev Neurosci"},{"key":"BF4001490_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1469-7793.2000.00373.x","volume":"529","author":"S Koyama","year":"2000","unstructured":"Koyama S, Matsumoto N, Kubo C, Akaike N . Presynaptic 5-HT3 receptor-mediated modulation of synaptic GABA release in the mechanically dissociated rat amygdala neurons. J Physiol Lond 2000; 529: 373\u2013383.","journal-title":"J Physiol Lond"},{"key":"BF4001490_CR11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1517\/13543776.6.5.471","volume":"6","author":"PH Silverstone","year":"1996","unstructured":"Silverstone PH, Greenshaw AJ . 5-HT3 receptor antagonists. Exp Opin Ther Pathol 1996; 6: 471\u2013481.","journal-title":"Exp Opin Ther Pathol"},{"key":"BF4001490_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0165-6147(92)90041-4","volume":"13","author":"GP Reynolds","year":"1992","unstructured":"Reynolds GP . Developments in the drug treatment of schizophrenia. Trends Pharmacol Sci 1992; 13: 116\u2013121.","journal-title":"Trends Pharmacol Sci"},{"key":"BF4001490_CR13","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1523\/JNEUROSCI.18-16-06528.1998","volume":"18","author":"P De Deurwaerdere","year":"1998","unstructured":"De Deurwaerdere P, Stinus L, Spampinato U . Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors. J Neurosci 1998; 18: 6528\u20136538.","journal-title":"J Neurosci"},{"key":"BF4001490_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0014-2999(88)90528-6","volume":"155","author":"P Blandina","year":"1988","unstructured":"Blandina P, Goldfarb J, Green JP . Activation of a 5-HT3 receptor releases dopamine from rat striatal slice. Eur J Pharmacol 1988; 155: 349\u2013350.","journal-title":"Eur J Pharmacol"},{"key":"BF4001490_CR15","first-page":"803","volume":"251","author":"P Blandina","year":"1989","unstructured":"Blandina P, Goldfarb J, Craddock-Royal B, Green JP . Release of endogenous dopamine by stimulation of 5-hydroxytryptamine 3 receptors in rat striatum. J Pharmacol Exp Ther 1989; 251: 803\u2013809.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF4001490_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0014-2999(89)90402-0","volume":"163","author":"SM Sorensen","year":"1989","unstructured":"Sorensen SM, Humphreys TM, Palfreyman MG . Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons. Eur J Pharmacol 1989; 163: 115\u2013118.","journal-title":"Eur J Pharmacol"},{"key":"BF4001490_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/j.1476-5381.1987.tb11394.x","volume":"92","author":"B Costall","year":"1987","unstructured":"Costall B, Domeney AM, Naylor RJ, Tyers MB . Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br J Pharmacol 1987; 92: 881\u2013894.","journal-title":"Br J Pharmacol"},{"key":"BF4001490_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0166-4328(96)81316-7","volume":"73","author":"RY Wang","year":"1996","unstructured":"Wang RY, Ashby Jr CR, Zhang JY . Modulation of the A10 dopamine system: electrophysiological studies of the role of 5-HT3-like receptors. Behav Brain Res 1996; 73: 7\u201310.","journal-title":"Behav Brain Res"},{"key":"BF4001490_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/npp.1993.13","volume":"8","author":"JA Apud","year":"1993","unstructured":"Apud JA . The 5-HT3 receptor in mammalian brain: a new target for the development of psychotropic drugs? Neuropsychopharmacol 1993; 8: 117\u2013130.","journal-title":"Neuropsychopharmacol"},{"key":"BF4001490_CR20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1001\/archpsyc.1992.01820090079013","volume":"49","author":"JW Newcomer","year":"1992","unstructured":"Newcomer JW, Faustman WO, Zipursky RB, Csernansky JG . Zacopride in schizophrenia: a single-blind serotonin type 3 antagonist trial. Arch Gen Psychiatry 1992; 49: 751\u2013752.","journal-title":"Arch Gen Psychiatry"},{"key":"BF4001490_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0165-6147(96)01034-6","volume":"18","author":"SZ Langer","year":"1997","unstructured":"Langer SZ . 25 years since the discovery of presynaptic receptors: present knowledge and future perspectives. Trends Pharmacol Sci 1997; 18: 95\u201399.","journal-title":"Trends Pharmacol Sci"},{"key":"BF4001490_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0014-2999(90)90043-6","volume":"182","author":"KJ Watling","year":"1990","unstructured":"Watling KJ, Beer MS, Stanton JA, Newberry NR . Interaction of the atypical neuroleptic clozapine with 5-HT3 receptors in the cerebral cortex and superior cervical ganglion of the rat. Eur J Pharmacol 1990; 182: 465\u2013472.","journal-title":"Eur J Pharmacol"},{"key":"BF4001490_CR23","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1006\/bbrc.1996.1278","volume":"225","author":"B Hermann","year":"1996","unstructured":"Hermann B, Wetzel CH, Pestel E, Zieglg\u00e4nsberger W, Holsboer F, Rupprecht R . Functional antagonistic properties of clozapine at the 5-HT3 receptor. Biochem Biophys Res Commun 1996; 225: 957\u2013960.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF4001490_CR24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1124\/mol.53.2.202","volume":"53","author":"S Lankiewicz","year":"1998","unstructured":"Lankiewicz S, Lobitz N, Wetzel CH, Rupprecht R, Gisselmann G, Hatt H . Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine 3 receptor cDNA and its splice variants from guinea pig. Mol Pharmacol 1998; 53: 202\u2013212.","journal-title":"Mol Pharmacol"},{"key":"BF4001490_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0143-4179(91)90080-3","volume":"19","author":"HM Malone","year":"1991","unstructured":"Malone HM, Peters JA, Lambert JJ . Physiological and pharmacological properties of 5-HT3 receptors \u2014 a patch clamp study. Neuropeptides 1991; 19: 25\u201330.","journal-title":"Neuropeptides"},{"key":"BF4001490_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0028-3908(97)00059-2","volume":"36","author":"M Barann","year":"1997","unstructured":"Barann M, Gothert M, Bonisch H, Dybeck A, Urban . 5-HT3 receptors in outside-out patches of N1E-115 neuroblastoma cells: basic properties and effects of pentobarbital. Neuropharmacology 1997; 36: 655\u2013664.","journal-title":"Neuropharmacology"},{"key":"BF4001490_CR27","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1210\/mend.12.9.0163","volume":"12","author":"CH Wetzel","year":"1998","unstructured":"Wetzel CH, Hermann B, Behl C, Pestel E, Rammes G, Zieglg\u00e4nsberger W et al. Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. Mol Endocrinol 1998; 12: 1441\u20131451.","journal-title":"Mol Endocrinol"},{"key":"BF4001490_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0304-3940(01)01872-9","volume":"306","author":"G Rammes","year":"2001","unstructured":"Rammes G, Rupprecht R, Ferrari U, Zieglg\u00e4nsberger W, Parsons CG . The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2\/579 and other amino-alkyl-cyclohexanes antagonise 5-HT3 receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neurosci Lett 2001; 306: 81\u201384.","journal-title":"Neurosci Lett"},{"key":"BF4001490_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/BF02191578","volume":"243","author":"B Bondy","year":"1994","unstructured":"Bondy B, Klages U, Muller-Spahn F, Hock C . Cytosolic free [Ca2+] in mononuclear blood cells from demented patients and healthy controls. Eur Arch Psychiatry Clin Neurosci 1994; 243: 224\u2013228.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"BF4001490_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/0003-2697(80)90515-1","volume":"107","author":"PJ Munson","year":"1980","unstructured":"Munson PJ, Rodbard D . Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107: 220\u2013239.","journal-title":"Anal Biochem"},{"key":"BF4001490_CR31","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1046\/j.1432-1327.2000.01280.x","volume":"267","author":"G Gimpl","year":"2000","unstructured":"Gimpl G, Fahrenholz F . Human oxytocin receptor in cholesterol-rich vs cholesterol-poor microdomains of the plasma membrane. Eur J Biochem 2000; 267: 2483\u20132497.","journal-title":"Eur J Biochem"},{"key":"BF4001490_CR32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/0304-3940(94)90185-6","volume":"173","author":"P Fan","year":"1994","unstructured":"Fan P . Inhibition of a 5-HT3 receptor-mediated current by the selective serotonin uptake inhibitor, fluoxetine. Neurosci Lett 1994; 173: 210\u2013212.","journal-title":"Neurosci Lett"},{"key":"BF4001490_CR33","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.mp.4001314","volume":"8","author":"B Eisensamer","year":"2003","unstructured":"Eisensamer B, Rammes G, Gimpl G, Shapa M, Ferrari U, Hapfelmeier G et al. Antidepressant are functional antagonists at the serotonin type 3 (5-HT3) receptor. Mol Psychiatry 2003; 8: 994\u20131007.","journal-title":"Mol Psychiatry"},{"key":"BF4001490_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1124\/mol.55.2.269","volume":"55","author":"MP Blanton","year":"1999","unstructured":"Blanton MP, Xie Y, Dangott LJ, Cohen JB . The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid\u2013protein interface. Mol Pharmacol 1999; 55: 269\u2013278.","journal-title":"Mol Pharmacol"},{"key":"BF4001490_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/16941","volume":"397","author":"PA Davies","year":"1999","unstructured":"Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG . The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature 1999; 397: 359\u2013363.","journal-title":"Nature"},{"key":"BF4001490_CR36","first-page":"1120","volume":"46","author":"AC Hargreaves","year":"1994","unstructured":"Hargreaves AC, Lummis SC, Taylor CW . Ca2+ permeability of cloned and native 5-hydroxytryptamine type 3 receptors. Mol Pharmacol 1994; 46: 1120\u20131128.","journal-title":"Mol Pharmacol"},{"key":"BF4001490_CR37","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1038\/sj.bjp.0704608","volume":"135","author":"K Yokota","year":"2002","unstructured":"Yokota K, Tatebashi H, Matsuo T, Shoge T, Motomura H, Matsuno T et al. The effects of neuroleptics on the GABA-induced Cl\u2212 current in rat dorsal root ganglion neurons: differences between some neuroleptics. Br J Pharmacol 2002; 135: 1547\u20131555.","journal-title":"Br J Pharmacol"},{"key":"BF4001490_CR38","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/S0028-3908(01)00007-7","volume":"40","author":"GC Terstappen","year":"2001","unstructured":"Terstappen GC, Pula G, Carignani C, Chen MX, Roncarati R . Pharmacological characterisation of the human small conductance calcium-activated potassium channel hSK3 reveals sensitivity to tricyclic antidepressants and antipsychotic phenothiazines. Neuropharmacology 2001; 40: 772\u2013783.","journal-title":"Neuropharmacology"},{"key":"BF4001490_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0169-328X(03)00175-X","volume":"115","author":"ZH Zhang","year":"2003","unstructured":"Zhang ZH, Lee YT, Rhodes K, Wang K, Argentieri TM, Wang Q . Inhibitory effects of pimozide on cloned and native voltage-gated potassium channels. Mol Brain Res 2003; 115: 29\u201338.","journal-title":"Mol Brain Res"},{"key":"BF4001490_CR40","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1523\/JNEUROSCI.22-02-00396.2002","volume":"22","author":"CM Santi","year":"2002","unstructured":"Santi CM, Cayabyab FS, Sutton KG, McRory JE, Mezeyova J, Hamming KS et al. Differential inhibition of T-type calcium channels by neuroleptics. J Neurosci 2002; 22: 396\u2013403.","journal-title":"J Neurosci"},{"key":"BF4001490_CR41","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S0149-7634(99)00067-6","volume":"23","author":"A Meneses","year":"1999","unstructured":"Meneses A . 5-HT system and cognition. Neurosci Biobehav Rev 1999; 23: 1111\u20131125.","journal-title":"Neurosci Biobehav Rev"},{"key":"BF4001490_CR42","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/BF02249414","volume":"125","author":"H Hodges","year":"1996","unstructured":"Hodges H, Sowinski P, Turner JJ, Fletcher A . Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system. Psychopharmacology 1996; 125: 146\u2013161.","journal-title":"Psychopharmacology"},{"key":"BF4001490_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0197-4580(96)00162-5","volume":"18","author":"AF Arnsten","year":"1997","unstructured":"Arnsten AF, Lin CH, Van Dyck CH, Stanhope KJ . The effects of 5-HT3 receptor antagonists on cognitive performance in aged monkeys. Neurobiol Aging 1997; 18: 21\u201328.","journal-title":"Neurobiol Aging"},{"key":"BF4001490_CR44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0165-6147(93)90128-7","volume":"14","author":"AJ Greenshaw","year":"1993","unstructured":"Greenshaw AJ . Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential. Trends Pharmacol Sci 1993; 14: 265\u2013270.","journal-title":"Trends Pharmacol Sci"},{"key":"BF4001490_CR45","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0165-1781(87)90090-4","volume":"20","author":"T Sunderland","year":"1987","unstructured":"Sunderland T, Cohen BM . Blood to brain distribution of neuroleptics. Psychiatry Res 1987; 20: 299\u2013305.","journal-title":"Psychiatry Res"},{"key":"BF4001490_CR46","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/BF02245121","volume":"108","author":"BM Cohen","year":"1992","unstructured":"Cohen BM, Tsuneizumi T, Baldessarini RJ, Campbell A, Babb SM . Differences between antipsychotic drugs in persistence of brain levels and behavioral effects. Psychopharmacology 1992; 108: 338\u2013344.","journal-title":"Psychopharmacology"},{"key":"BF4001490_CR47","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0006-3223(92)90085-E","volume":"32","author":"T Tsuneizumi","year":"1992","unstructured":"Tsuneizumi T, Babb SM, Cohen BM . Drug distribution between blood and brain as a determinant of antipsychotic drug effects. Biol Psychiatry 1992; 32: 817\u2013824.","journal-title":"Biol Psychiatry"},{"key":"BF4001490_CR48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/sj.bjp.0703540","volume":"131","author":"WA Daniel","year":"2000","unstructured":"Daniel WA, Syrek M, Haduch A, Wojcikowski J . Pharmacokinetics and metabolism of thioridazine during co-administration of tricyclic antidepressants. Br J Pharmacol 2000; 131: 287\u2013295.","journal-title":"Br J Pharmacol"},{"key":"BF4001490_CR49","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1176\/ajp.156.6.885","volume":"156","author":"J Kornhuber","year":"1999","unstructured":"Kornhuber J, Schultz A, Wiltfang J, Meineke I, Gleiter CH, Zochling R et al. Persistence of haloperidol in human brain tissue. Am J Psychiatry 1999; 156: 885\u2013890.","journal-title":"Am J Psychiatry"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4001490.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4001490","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4001490.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:34:56Z","timestamp":1648784096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4001490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,16]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9,1]]}},"alternative-id":["BF4001490"],"URL":"https:\/\/doi.org\/10.1038\/sj.mp.4001490","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,16]]},"assertion":[{"value":"16 August 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2003","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2004","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2004","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}